LungLife AI, Inc. Sustainability Profile
LungLife AI, Inc., headquartered in the United States, is a pioneering company in the healthcare technology sector, specialising in advanced diagnostic solutions for lung cancer. Founded in 2018, LungLife AI has made significant strides in leveraging artificial intelligence to enhance the accuracy and efficiency of lung cancer detection, positioning itself as a leader in the oncology diagnostics market. The company’s flagship product, the LungLife AI platform, utilises cutting-edge machine learning algorithms to analyse patient data, providing clinicians with actionable insights that improve patient outcomes. This innovative approach not only streamlines the diagnostic process but also sets LungLife AI apart from traditional methods. With a commitment to transforming lung cancer care, LungLife AI continues to achieve notable milestones, solidifying its reputation as a key player in the fight against this prevalent disease.
DitchCarbon Score
How does LungLife AI, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LungLife AI, Inc.'s score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LungLife AI, Inc.'s reported carbon emissions
In 2022, LungLife AI, Inc. reported total carbon emissions of approximately 1,347,800 kg CO2e, comprising 404,000 kg CO2e from Scope 1, 282,600 kg CO2e from Scope 2, and 661,200 kg CO2e from Scope 3 emissions. This data reflects a significant operational footprint, with the majority of emissions stemming from Scope 3, which typically includes indirect emissions from the supply chain and product use. In 2021, the company reported a much higher Scope 1 emission total of approximately 533,000,000 kg CO2e, indicating a substantial reduction in direct emissions in the following year. However, no specific reduction targets or climate pledges have been documented, and there are no cascading emissions data from a parent or related organization. LungLife AI, Inc. is committed to addressing its carbon footprint, although specific initiatives or targets have not been outlined. The absence of formal reduction commitments suggests an opportunity for the company to enhance its climate strategy in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 533,000,000 | 000,000 |
| Scope 2 | - | 000,000 |
| Scope 3 | - | 000,000 |
How Carbon Intensive is LungLife AI, Inc.'s Industry?
How Carbon Intensive is LungLife AI, Inc.'s Location?
LungLife AI, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LungLife AI, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Thermo Fisher Scientific
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.